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Justine Debelius1, Se Jin Song1,2, Yoshiki Vazquez-Baeza3, Zhenjiang Zech Xu1, Antonio Gonzalez1
and Rob Knight1,3*Abstract
Many factors affect the microbiomes of humans, mice,
and other mammals, but substantial challenges remain
in determining which of these factors are of practical
importance. Considering the relative effect sizes of both
biological and technical covariates can help improve
study design and the quality of biological conclusions.
Care must be taken to avoid technical bias that can lead
to incorrect biological conclusions. The presentation of
quantitative effect sizes in addition to P values will
improve our ability to perform meta-analysis and to
evaluate potentially relevant biological effects. A better
consideration of effect size and statistical power will lead
to more robust biological conclusions in microbiome
studies.taxa and disease has been especially problematic, in part
because of differences in how studies define clinicalIntroduction
The human microbiome is a virtual organ that con-
tains >100 times as many genes as the human genome
[1]. In the past 10 years, our understanding of associa-
tions between the microbiome and health has expanded
greatly. Our microbial symbionts have been implicated in
a broad range of conditions including: obesity [2, 3];
asthma, allergies, and autoimmune conditions [4–10]; de-
pression (reviewed in [11, 12]) and other mental illnesses
[13, 14]; neurodegeneration [15–17]; and vascular disease
[18, 19]. Nevertheless, integrating this rapidly expanding
literature to find general patterns is challenging because of
the myriad ways in which differences are reported. For ex-
ample, the term 'dysbiosis’ may reflect differences in alpha
diversity (the biological diversity within a sample) [13], in
beta diversity (the difference in microbial community* Correspondence: robknight@ucsd.edu
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(http://creativecommons.org/publicdomain/zestructure between samples) [20], in the abundances of
specific bacterial taxa [7, 14, 15], or any combination of
these three components [4, 6]. All of these differences
might reflect real kinds of dysbiosis, but studies that focus
on different features are difficult to compare. Even draw-
ing generalities from different analyses of alpha diversity
can be complicated. It is well known that errors in se-
quencing and DNA sequence alignments can lead to
substantial inflation of counts of the species apparent
in a given sample [21–25]. Moreover, different measures
of diversity focusing on richness (the number of kinds of
entities), evenness (whether all entities in the sample have
the same abundance distribution), or a combination of
these can produce entirely different results than ranking
samples by diversity.
Establishing consistent relationships between specific
populations, handle sample preparation and DNA-
sequencing methodology, and use bioinformatics tools
and reference databases, all of which can affect the re-
sult substantially [26–29]. A literature search may find
that the same taxon has been both positively and nega-
tively associated with a disease state in different studies.
For example, the Firmicutes to Bacteriodetes ratio was
initially thought to be associated with obesity [30] and
was considered a potential biomarker [31], but our re-
cent meta-analysis showed no clear trend for this ratio
across different human obesity studies [32]. Some of
the problems could be technical, because differences in
sample handling can change the observed ratio of these
phyla [33] (although we would expect these changes to
cause more issues when comparing samples between
studies than when comparing those within a single study).
Consequently, identifying specific microbial biomarkers
that are robust across populations for obesity (although,
interestingly, not for inflammatory bowel disease) remains
challenging. Different diseases will likely require different
approaches.le is distributed under the terms of the Creative Commons Attribution 4.0
.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
ive appropriate credit to the original author(s) and the source, provide a link to
changes were made. The Creative Commons Public Domain Dedication waiver
ro/1.0/) applies to the data made available in this article, unless otherwise stated.
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microbiome studies, we are beginning to understand how
the effect size can help to explain differences in community
profiling. In statistics, effect size is defined as a quantitative
measure of the differences between two or more groups,
such as a correlation coefficient between two variables or a
mean difference in abundance between two groups. For ex-
ample, the differences in overall microbiome composition
between infants and adults are so large that they can be
seen even across studies that use radically different
methods [34]; this is because the relative effect size of age
is larger than that of processing technique. Therefore, des-
pite problems in generalizing findings across some micro-
biome studies that result from the factors noted above, we
are beginning to understand how the effect sizes of specific
biological and technical variables in community profiling
are structured relative to others.
In this review, we argue that by explicitly considering
and quantifying effect sizes in microbiome studies, we can
better design experiments that limit confounding factors.
This principle is well established in other fields, such as
ecology [35], epidemiology (see for example [36]), andTable 1 The relative effects of biological covariates affecting the mi
Covariate References Findings
Large
Host species [41–44] The gut microbiom
Animals that have
that are adapted to
Age [45, 46, 52] Infants have drama
of developmental
of older children b
community structu
Lifestyle [45, 54] Western adults and
have large differen
Medium
Antibiotic use [55, 56, 58, 59] Antibiotics have a
structure and lowe
and different antib
Medium to small; difficult to rank
Long-term dietary patterns [61, 62] A low-fiber diet lea
returning to a high
Non-antibiotic xenobiotics [69–73] Drugs including ac
microbiome. Micro
Genetics [3, 66, 67] Identical twins hav
Some clades are h
an ancestral group
Exercise [63–65] Extreme athletes h
It is, however, diffic
models suggest th
Pet ownership and cohabitation [68] Individuals living to
microbiomes than
effect is on the skin
Small
Short-term dietary intervention [61, 74] Short-term diet ma
configuration oncegenome-wide association studies (their relationship to
microbiome studies is reviewed in [37]). Avoiding import-
ant confounding variables that have a large effect size will
allow researchers to more accurately and consistently
draw meaningful biological conclusions from these studies
of complex systems.Biological factors that affect the microbiome
Specific consideration of effect sizes is crucial for inter-
preting naturally occurring biological variation in the
microbiome, where the effect being investigated is fre-
quently confounded by other factors that might affect
the observed community structure. Study designs must
consider the relative scale of different biological effects
(for example, microbiome changes induced by diet, drugs,
or disease) and technical effects (for example, the effects
of PCR primers or DNA extraction methods) when select-
ing appropriate controls and an appropriate sample size.
To date, biological factors with effects on the microbiome
of varying sizes have been observed (Table 1). Consider,
for example, the effect of diet on the microbiome.crobiome
e of host species separates by dietary patterns and phylogeny.
diets that diverge from those of their ancestors have microbiomes
their new diets.
tically different microbiomes to adults, and undergo a rapid period
maturation. After the introduction of solid food, the microbiomes
egin to resemble those of their parents and move toward an adult
re.
adults living traditional lifestyles (e.g., agriculturists, hunter-gatherers)
ces in their microbiomes.
sustained effect on the microbiome, leading to altered community
r alpha diversity. Individualized responses to the same antibiotic vary,
iotics may have different impacts.
ds to the loss of species, although diversity can be recovered by
-fiber diet.
tominopin, proton pump inhibitors, and metformin alter the
bial metabolism may contribute to side effects associated with drugs.
e microbiomes that have more similarity than those of fraternal twins.
eritable, although the heritability varies. Microbes that coevolved with
may be better symbionts.
ave different microbiomes than sex-, age-, and weight-matched controls.
ult to separate the effect of diet from the effect of exercise. Mouse
at exercise alone has an impact.
gether—whether genetically related or unrelated—share more of their
people who do not cohabitate. Pets act as vectors, although their largest
microbiome.
y change microbial communities, but they return to the previous
the intervention has ended.
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that composition of the gut microbial community varies
strongly with diet, a trait that tends to be conserved
within animal taxonomic groups [38–40]. For example, in
a landmark study of the gut microbiomes of major mam-
malian groups, Ley et al. [41] showed that diet classifica-
tion explained more variation across diverse mammalian
microbiomes than any other variable (although different
gut physiologies are generally adapted to different diets, so
separating these variables is difficult). However, a separate
study of foregut and hindgut fermenting avian and rumin-
ant species found that gut physiology explained the largest
amount of gut microbiome variation [42], suggesting that
diet may have been a confounding variable. More studies
are now beginning to tease apart the relative effects of diet
and other factors, such as taxonomy, by considering
multiple animal lineages, such as panda bears and ba-
leen whales, that have diets that diverge from those of
their ancestors [43, 44].
Even within a single species, diet has been shown to
shape the gut microbial community significantly. In humans,
for example, changes in the gut microbiome associated with
diet shifts in early development are consistent across
populations, as the microbiomes of infants and toddlers
systematically differ from those of adults [45, 46]. Al-
though the microbiome continues to change over the
course of a person’s life, the magnitudes of differences
over time are much smaller in adults than in infants.
The early differences are, in part, due to changes in
diet, although it may be hard to decouple diet-specific
changes from overall developmental changes. The micro-
biome developmental trajectory for infants may begin
even before birth: the maternal gut and vaginal micro-
biome change during pregnancy. The gut microbiome of
mothers in the third trimester, regardless of health status
and diet, enters a proinflammatory configuration [47].
The vaginal microbiome has reduced diversity and a
characteristic taxonomic composition during pregnancy
[48, 49], which may be associated with the transfer of
specific beneficial microbes to the infant. During delivery,
neonates acquire microbial communities that reflect their
delivery method. The undifferentiated microbial commu-
nities of vaginally delivered babies are rich in Lactobacil-
lus, a common vaginal microbe, whereas those of infants
born by cesarean are dominated by common skin mi-
crobes including Streptococcus [50].
Over the first few months of life, the infant micro-
biome undergoes rapid changes [46], some of which cor-
relate with changes in breast milk composition and the
breast milk microbiome [51]. Formula-fed infants also
have microbial communities that are distinct from those
of breastfed babies [52, 53]; formula was associated with
fewer probiotic bacteria and with microbial communities
closer than those of breastfed babies to the microbialcommunities of adults. The introduction of solid food
has been associated with dramatic changes in the micro-
biome, during which toddlers come to more closely re-
semble their parents [45, 46, 52]. The compositional
difference between infants and adults is larger than the
differences resulting from compounded technical ef-
fects across studies [34], suggesting that this difference
between human infants and adults is one of the largest
effects on gut microbial community in humans.
Within children and adults, studies suggest that changes
in the gut microbiome could stem from dietary changes
corresponding to technological advancement, including
shifts from a hunter-gatherer to an agrarian or industri-
alized society [45, 54]. These differences may be con-
founded, however, by other non-diet-related factors that
co-vary with these shifts, such as exposure to antibiotics
[55, 56] or the movement of industrialized individuals into
confined, more sterile buildings [57]. Antibiotic-induced
changes in the microbiome can last long after the course
of treatment is completed [56, 58]. Although differences
in microbial communities resulting from antibiotic use
can be seen [56], different individuals respond differently
to a single antibiotic [59]. At this scale, some technical ef-
fects, such as those associated with differences in sequen-
cing platforms or reagent contamination, are smaller than
the biological effect and can be corrected for using
sequence data processing and statistical techniques.
Nevertheless, compounded effects may lead to differ-
ences between studies that are larger than the bio-
logical effect being examined. It is often possible to see
clear separation between communities using Principal
Coordinates Analysis (PCoA) space even with cross-
sectional data. PCoA provides a quick visualization tech-
nique for assessing which effects are large and which are
small in terms of the degree of difference in a reduced-
dimensionality space, although statistical confirmation
using techniques such as ANOSIM or PERMANOVA is
also necessary. Essentially, factors that led to groups of
samples separating more in PCoA space have larger ef-
fects. One important caveat is that the choice of distance
metric can have a large effect on this clustering [60].
On a finer scale, for example when considering only
Western human populations, the effects of individual diet
are less pronounced. Long-term dietary patterns, however,
have been shown to alter the microbiome [61]. Several
mouse models have demonstrated a mechanistic role for
diet. In one study, mice were humanized with stool from
lean or obese donors. Cohousing obese mice with lean
mice led to weight loss only if the obese mouse was fed a
high-fiber diet [2]. Another study using humanized gnoto-
biotic mice (that is, initially germ-free mice colonized with
human-derived microbes) showed that a low-fiber diet led
to a significant loss of diversity, and that the changes in
the microbiome were transmitted to pups [62]. Increasing
Debelius et al. Genome Biology  (2016) 17:217 Page 4 of 12the fiber in the mouse’s diet led to an increase in micro-
biome diversity [62]. Nevertheless, it can be hard to separ-
ate long-term dietary patterns from other factors that
shape individual microbial communities. For example, ex-
ercise is hypothesized to alter the microbiome [63–65].
One study found differences between extreme athletes and
age- and weight-matched controls [64]. It is unclear, how-
ever, whether these differences are due to the strenuous
training regime, the dietary requirements of the exercise
program, or a combination of these two factors [63, 64]. At
this scale, cross-sectional data may overlap in PCoA space.
Host genetics help to shape microbial communities.
Identical twins share slightly more of their overall micro-
bial communities than do fraternal twins [3, 66], al-
though some taxa are far more heritable than others.
Cross-sectional studies suggest that the coevolution of
bacteria and human ancestors can also shape disease
risk: the transfer of Helicobacter pylori strains that evolved
separately from their host may confer a higher risk of gas-
tric cancer [67]. However, separating the effect of genetics
from those of vertical transmission from mother to child
[52] or of transfer due to cohabitation with older children
can be difficult, and the relative effect sizes of these factors
is unknown [68].
Cohabitation and pet ownership modify microbial
communities, and their effects can be confounded with
those of diet (which is often shared within a household).
Spouses are sometimes used as controls, because they
are hypothesized to have similar diets. However, cohabi-
tating couples can share more of their skin microbiomes,
and to a lesser extent their gut microbiomes, than cou-
ples who do not live together [68]. Dog ownership also
influences the similarity of the skin, but not fecal, micro-
bial community [68].
Exposure to chemicals other than antibiotics also shapes
our microbiome, and microbes may in turn shape our re-
sponses to these chemicals. There is mounting evidence
that use of pharmaceuticals—both over-the-counter
[69] and prescription [70–73]—leads to changes in mi-
crobial community structures. For example, metformin
use was correlated with a change in the microbiome of
Swedish and Chinese adults with type II diabetes [72].
(Notably, in this study, the failure to reproduce taxo-
nomic biomarkers that were associated with disease in
the two populations was due to different prevalence of
metformin use, which has a large effect on the micro-
biome; the drug was used only in diabetes cases and
not in healthy controls.) Changes in the microbiome
may also be linked to specific side effects; for example,
metformin use improved not only glucose metabolism
but also pathways contributing to gas and intestinal dis-
comfort. Which of these factors contributed most to
microbiome changes is difficult to resolve with the
available data [72].Within a single individual, short-term or long-term in-
terventions present the largest potential for remediation,
but the effects of interventions often vary and method-
ology matters. A study that looked for a consistent
change in the microbiome in response to a high- or low-
fiber diet found no differences [43]. A group focusing on
a mostly meat or mostly plant diet found a difference in
community structure only when considering relative
change in community structure, and did not find that
communities from different people converged on a com-
mon state overall [74].
Technical factors affecting the microbiome
Technical sources of variation have a large influence on
the observed structure of the microbial community, often
on scales similar to or larger than biological effects.
Considerations include sample collection and storage
techniques, DNA extraction method, selection of hyper-
variable region and PCR primers, sequencing method, and
bioinformatics analysis method (Fig. 1, Table 2).
An early consideration in microbiome studies is sam-
ple collection and storage. Stool samples can be collected
using a bulk fecal sample or a swab from used toilet paper
[75]. The gold standard for microbial storage is freezing
samples at −80 °C. Recent studies suggest that long-term
storage at room temperature can alter sample stability.
Preservation methods such as fecal occult blood test
cards, which are used in colon cancer testing [76, 77], or
storage with preservatives [76] offer better alternatives.
Freeze-thaw cycles should be avoided because they affect
reproducibility [78]. Nevertheless, some studies have
found that preservation buffers alter the observed com-
munity structure [79]. Preservation method seems to have
a larger impact on observed microbial communities than
collection method, although it is not sufficient to over-
come inter-individual variation [76].
Sample processing plays a large role in determining
the observed microbiota. DNA extraction methods vary
in their yields, biases, and reproducibility [80, 81]. For
example, the extraction protocols used in the Human
Microbiome Project (HMP) and the European MetaHIT
consortium differed in the kingdoms and phyla extracted
[81]. Similarly, the DNA target fragment and primer se-
lection can create biases. Although the V2 and V4 re-
gions of the 16S rRNA gene are better than others for
broad phylogenetic classification [82], these regions
often yield results that differ from each other, even when
combined with mapping to a common set of full-length
reference sequences. For example, all the HMP samples
were sequenced using primers targeting two different
hypervariable regions of the 16S rRNA gene [83]. The
separation of samples in PCoA space indicates that the
technical effect of different primer regions is larger than
any of the biological effects within the study (Fig. 2).
(a) (b)
(c) (d)
PC2 (6.5%)
PC1 (16.3%)
PC3 (5.7%)
PC2 (6.5%)
PC1 (16.3%)
PC3 (5.7%)
PC2 (10.8%)
PC1 (13.6%)
PC3 (5.3%)
PC2 (10.8%)
PC1 (13.6%)
PC3 (5.3%)
Airways
GI tract
Oral
Skin
Urogenital tract
V 1-3
V 3-5
Keratinized gingiva
Buccal muscosa
Hard palate
Palantine tonsils
Saliva
Subgingal plaque
Supergingival plaque
Throat
Tongue dorsum
V 1-3
V 3-5
Fig. 1 PCoA differences in PCR primers can outweigh differences among individuals within one body site, but not the differences between different
body sites. In the Human Microbiome Project (HMP) dataset, when V1-3 and V3-5 primers are combined across body sites, a the effect of PCR primers
is small compared to b the effect of body site. However, if we analyze individual body sites such as c the mouth or d the mouth subsites, the effect of
primer is much greater than the difference between different individuals (or even of different locations within the mouth) at that specific body site.
GI gastrointestinal
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effect on the observed community structure. Longer
reads can improve classification accuracy [82], but only
if the sequencing technology does not introduce add-
itional errors.
Choices in data processing also play a role in the bio-
logical conclusions reached in a study or set of combined
studies. Read trimming may be necessary to normalize
combined studies [34], but shorter reads can affect the ac-
curacy of taxonomic classifications [82]. The selection of a
method to map sequences into microbes has a largeTable 2 Technical factors affecting the microbiome
Covariate References Findings
Sample storage [76–79] The gold standard f
multiple freeze-thaw
methods improve s
Primers and sequencing
method
[32, 34, 82, 83] Primer selection and
Resolution is better
Extraction kit and kit lot [80, 81, 90, 91] Extraction kit alters
bacteria will be obs
kit can have a large
Bioinformatics [22, 61, 74, 84, 85, 88] Clustering method,
quality filtering influ
statistical analysis animpact on the microbial communities identified. Several
approaches exist, but clustering of sequences into
Operational Taxonomic Units (OTUs) on the basis of
some threshold is common. Sequences may be clustered
against themselves [22, 84], clustered against a reference
[84], or clustered against a combination of the two [85].
The selection of a particular OTU clustering method and
OTU clustering algorithm alters the observed microbial
community and can artificially inflate the number of
OTUs observed [22, 84]. De-noising (a technique
commonly used with 454 sequencing [22]), removal ofor storage is −80 °C. Long-term storage at room temperature or
cycles alter community stability. Room temperature preservation
tability but may alter microbial community structure.
hypervariable region influence the observed microbial community.
with longer reads and the V2 and V4 regions of the 16S rRNA.
the observed community by increasing the probability that certain
erved. In low-biomass samples, reagent contamination in the extraction
r effect on the observed community than the biological effect of interest.
choice of reference, chimera removal, or de-noising method and
ence results and taxonomic assignments. Additionally, the choice of
d data visualization can lead to conflicting conclusions with similar data.
0.4
0.2
0.0
-0.2
-0.4
(a)
0.4
0.2
P
C
2
PC1
0.0
-0.2
-0.4
-0.4 -0.2 0.04 0.2 0.4
(d)
0.4
0.2
0.0
-0.2
-0.4
-0.4 -0.2 0.04 0.2 0.4
(g)
-0.4 -0.2 0.04 0.2 0.4
(h)
(b)
(e)
(c)
(f)
Fig. 2 PCoA patterns of technical and biological variation. Two groups (black, gray) with significantly different distances (P < 0.05) and varying
effect size. a A large separation in PCoA space and large effect size. Separation in PCoA space (shown here in the first two dimensions) may be
caused by technical differences in the same sample set, such as different primer regions or sequence lengths. b Clear separation in PCoA space,
similar to patterns seen with large biological effects. In cross-sectional studies, age comparisons between young children and adults or comparisons
between Western and nonWestern adults might follow this pattern. c Moderate biological effect. d Small biological effect. Sometimes effects can be
confounded. In e the technical effect and in f the biological effect are conflated because the samples were not randomized. In g and h, there is a
technical and a biological effect, but the samples were randomized among conditions, so the relative size of these effects can be measured
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quality filtering of Illumina data can help to alleviate some
of these problems [24, 88]. After OTU picking, the selec-
tion of biological criteria, ecological metric, and statistical
test can lead to different biological conclusions [60, 89].
The degree to which technical variation impacts bio-
logical conclusions depends on the relative scale of the
effects and the method of comparison. For very large ef-
fects, biologically relevant patterns may be reproducible
when studies are combined even though there is technical
variability. A comparison of fecal and oral communities in
adult humans may be robust to multiple technical effects,
such as differences in extraction method, PCR primers,
and sequencing technology (Fig. 2). Conversely, subtle
biological effects can quickly become swamped. Many
biological effects of interest to current research have a
smaller effect on observed microbial communities than
the technical variations commonly observed among
studies [32, 34].
Failure to consider technical variation can also confound
biological interpretation. In low-biomass samples, tech-
nical confounders such as reagent contamination can havelarger effects than the biological signal. A longitudinal
study of nasopharyngeal samples from young children
[90] exemplified this effect. Principal Coordinates Analysis
of the data found a sharp distinction by age. It was later
determined, however, that the samples had been extracted
with reagents from two different lots—the differences in
the microbial communities were due to reagent contamin-
ation and not biological differences [91]. Higher biomass
samples are not immune to this problem. Extraction of
case and control samples using two different protocols
could potentially lead to similar erroneous conclusions.
Comparing effects: the importance of large
integrated studies
Large-scale integration provides a common framework
for comparing effects. Studies of large populations are
often successful in capturing the significance of biological
patterns such as age [45], human microbiome compos-
ition [75, 92], or specific health conditions such as Crohn’s
disease [93]. The scale of the population means that mul-
tiple effects can also be compared across the same set of
samples. For example, the HMP provided a reference map
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[92]. Yatsunenko et al. [45] highlight the effect of age over
other factors including weight and country of origin, dem-
onstrating that age has a larger effect on the microbiome
than nationality, which in turn has a larger effect than
weight (Fig. 3). Two recently published studies of Belgian
and Dutch populations provide very interesting examples
of what can be achieved through larger population-based
studies, especially in terms of understanding which factors
are important in structuring the microbiome.
The LL-Deep study, which used both 16S rRNA
amplicon sequencing and shotgun metagenomic sequen-
cing on a cohort of 1135 Dutch individuals, associated
110 host factors to 125 microbial species identified by
shotgun metagenomics. In particular, this study found
that age, stool frequency, dietary variables such as total
carbohydrates, plants and fruits, and fizzy drinks (both
'diet' brands and those with sugar) had large effects, as
did drugs such as proton pump inhibitors, statins, and
antibiotics [94]. Interestingly, the authors observed 90 %
concordance in associations between the shotgun meta-
genomic and the rRNA amplicon results, suggesting that
many conclusions about important microbiome effects
may be robust to some kinds of methodological vari-
ation, even if the absolute level of specific taxa are not.
The Flemish Gut Flora Project, which used 16S rRNA
amplicon sequencing on a cohort of 1106 individuals,
identified 69 variables relating to the subjects that corre-
lated with the microbiome, including use of 13 drugs ran-
ging from antibiotics to antidepressants, and explained
7.7 % of the variation in the microbiome. The consistency
of the stool (which is a proxy for transit time), age, and
body mass index were especially influential, as was the fre-
quency of fruit in the diet; the adult subjects did not show
effects of early-life variables such as delivery mode or resi-
dence type during early childhood [95]. The American
Gut Project (www.americangut.org), now with over 10,000
samples processed, is a crowd-sourced microbiome studyPC2 (10.9%)
PC3 (4.3%)
PC1 (15.4%)
PC2 (10.9%)
PC3 (4.3%)
(a) (b)
Fig. 3 Relative effect sizes of biological covariates on the human microbiom
using data from Yatsunenko et al. [45], shows a age (blue gradient; missing
(USA, orange; Malawi, green; Venezuela, purple) separating the data along th
much more subtle effect, and does not separate along any of the first thre
missing samples, gray)that expands on the effects considered by the HMP to
evaluate microbial diversity across Western populations
with fewer restrictions on health and lifestyle. Large-scale
studies have two advantages for comparisons. They can
help to limit technical variability because samples within
the same study are collected and processed in the same
way. This reduces technical confounders, making it easier
to draw biological conclusions. Second, large population
studies increase the probability of finding subtle biological
effects which may be lost in the noise of smaller studies.
Meta-analyses that place smaller studies into the con-
text of these larger studies can also provide new insights
into the relative size of the changes seen in the smaller
studies [34]. Weingarden et al. [96] took advantage of
the HMP and contextualized the dynamics of fecal ma-
terial transplants (FMT). Their initial data set focused
on a time series from four patients who had recurrent
Clostridium difficile infection and a healthy donor. By
combining the time series results with a larger dataset,
they revealed the dramatic restoration that diseased
patients undergo after the transplant is administered,
ultimately helping the patients recover from the severe
C. difficile infection [96, 97].
When conducting a meta-analysis, however, it is im-
portant to consider whether the differences in microbial
communities in different studies are due to technical or
biological effects. Selecting studies that each include bio-
logically relevant controls can help to determine whether
the scale of the effect between the studies results from a
biological or a technical covariate. In the FMT study
[96], the donor (control) sample clustered with the HMP
fecal samples, while the pre-treatment recipients did not.
Had the donor point grouped somewhere else, perhaps
among the skin samples or in a completely separate loca-
tion, it could have indicated a large technical effect, sug-
gesting that the studies should not be combined into a
single PCoA (although trends might still be identified
within each study and compared). Similarly, a study of thePC1 (15.4%)
PC2 (10.9%)
PC3 (4.3%)
PC1 (15.4%)
(c)
e. Principal coordinates projection of unweighted UniFrac distance,
samples in red) separating the data along the first axis and b country
e second principal coordinates axis. c Body mass index in adults has a
e principal coordinate axes (normal, red; overweight, green; obese, blue;
Box 1. Methods for power analysis of microbiome data
The calculation of effect size in microbiome data is challenging
for several reasons. Operational Taxonomic Unit (OTU)-based
methods are affected by the sparsity of OTUs, meaning that
many samples may not contain a given taxon. This means that
OTUs do not fit the Gaussian distribution and/or non-correlated
observation assumptions required for common statistical tests,
such as t tests. While many methods exist to evaluate differences
in OTUs (reviewed in [107]), currently only one defines power-
based calculations.
The Dirichlet Multinomial method [101] models the variability and
frequency of an OTU within a population or across populations.
The data are fitted to a modified multinomial distribution. La Rosa
et al. [101] developed power and effect size calculations for the
Dirichlet multinomial model based on Cramer’s model for the chi-
square distributions [108]. A second technique for OTU-based
comparison is the application of random forest models for
supervised regression and classification. Random forest excels at
feature selection, identifying the most relevant OTUs that are
correlated with metadata and ranking features with their contribution
to the model. Power can be estimated by a learning curve,
comparing how well these features predict the metadata category
against the number of samples used in the training set.
Effect size calculations for diversity metrics, particularly beta
diversity, are also challenging because permutative tests are
required. For common parametric tests, power is defined on the
basis of the distribution of the test statistic [109]. Nonparametric
tests, including permutative tests, do not have a defined distribution
for the test statistic, so power is difficult to calculate [110, 111].
An emerging solution to effect size estimation is the use of
simulation to estimate statistical power. Kelly et al. [103]
proposed that power could be calculated from PERMANOVA
tests by estimating an effect size on the basis of the original data,
using an ANOVA-based estimator. They then simulated distance
matrices with the same properties as the original dataset, and
estimated power by bootstrapping the simulated distance matrices.
A second solution involves subsampling the data. The Evident
software package (https://github.com/biocore/Evident) relies on
subsampling the data to estimate visual separation between
groups. Monte Carlo simulations are used to estimate the
variance in a data cloud, and provide an estimate of visual
separation. The package allows exploration of both the
sampling depth and the number of samples. An extension of
the Evident protocol is to apply the same subsampling
procedure to a statistical test as an estimate of power. This
solution has been implemented in the scikit-bio software
package (http://scikit-bio.org/).
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2 years of life showed changes in the infant microbiome
with age [36], but it was only when this study was placed
in the context of the HMP that the scale of developmental
change within a single infant body site relative to differ-
ences in the microbiome among distinct human body sites
became clear [34].
Leveraging effect size in meta-analysis
Compared to other fields, meta-analysis among micro-
biome studies is still in its infancy. Statistical methods
can help to overcome the complication of technical ef-
fects in direct comparisons, allowing focus on the bio-
logical results. Medical drug trials [98, 99] routinely report
quantified effect sizes. This practice has several advan-
tages. First, it moves away from a common binary para-
digm of not significant or significant at P < 0.05 [35]. The
combination of significance and effect size can be import-
ant for avoiding undue alarm, as has been shown in other
fields. For instance, a recent meta-analysis found a statisti-
cally significant increase in cancer risk associated with red
meat consumption [100]. The relative risk of colon cancer
associated with meat consumption is, however, much
lower than the relative risk of colon cancer associated with
an inflammatory bowel disease (IBD) diagnosis. With a P
value alone, it might not have been possible to determine
which factor had a larger impact on cancer risk. Effect size
quantification may also help to capture the range of vari-
ation in effects across different populations: there are
probably multiple ways for a microbial community to be
'sick', rather than single set of taxa that are enriched or
depleted in perturbed populations. We see this, for ex-
ample, in the different 'obese' microbiomes that seem
to characterize different populations of obese individuals.
Finally, effect size is also closely linked to statistical power,
or the number of samples needed to reveal a statistical
difference. Quantitative power estimates could improve
experimental design and limit publication bias [35].
Unfortunately, effect size and statistical power are
challenging to calculate in microbiome data. Currently,
applied power calculations (reviewed in [35]) typically
make assumptions about the data that do not hold true
in the analysis of microbial communities (Box 1). Some
solutions to this problem have been proposed, including
the Dirichlet Multinomial method [101] and random
forest analysis [102] for OTUs, a simulation-based
method for PERMANOVA-based beta diversity compar-
isons [103], and power estimation by subsampling (Box
1). Nevertheless, power analysis remains rare in micro-
biome studies. New methods could facilitate better un-
derstanding of effect sizes. As the scope of microbiome
research continues to expand to include metabolomic,
metagenomics, and metatranscriptomic data, effect size
considerations will only become more important.
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Large-scale studies provide insight into which variables
have broad effects on the microbiome, but they are not
always feasible. Small, well-designed studies that address
hypotheses of limited scope have a large potential to ad-
vance the field. In designing one of these studies, it is
better to define a population of interest narrowly, rather
than trying to draw general conclusions. The design and
implementation of small studies should strive for four
goals: limited focus, rich metadata collection, appropri-
ate sample size, and minimized technical variation.
Limiting the scope of the study increases the probabil-
ity that a small study will be successful because it de-
creases noise and confounding factors. For example, the
hypothesis 'milk consumption alters the microbial com-
munity structure and richness in children' might be bet-
ter phrased as 'milk consumption affects the microbial
community structure and richness in children in third
through fifth grade attending New York Public schools'.
Additionally, the study should define exclusion criteria;
for example, perhaps children who have taken antibiotics
in the past 6 months or 1 year should be excluded
[56, 58]. Broader hypotheses may be better tackled in
meta-analyses, where multiple small, well-designed studies
on a similar topic can be combined.
Information about factors that might influence the
microbiome should be included in sample collection.
For example, the study of children attending New York
City Public Schools might not have birth delivery method
as an exclusion criterion, but whether the child was born
by C-section or vaginally could influence their microbial
community, so this information should be recorded and
analyzed. Self-reported data should be obtained using a
controlled vocabulary and common units. If multiple
small studies are planned, standard metadata collection
will minimize time in meta-analysis.
A second consideration in defining scope is to identify
a target sample size. Other studies may be used as a guide,
particularly if the data can be used to quantify an effect
size. Quantitative power calculations (Box 1) can be par-
ticularly helpful in defining a sample size. Nevertheless,
this comparison should be done judiciously. Sample sizes
should be estimated by selecting a known effect that is ex-
pected to be of similar scale. It may be prudent to consider
the phenotype associated with the effect, and whether the
effect might directly target microbes. For example, one
might guess that a new drug that inhibits folate metab-
olism, which is involved in DNA repair in bacteria and
eukaryotes, might have an effect close to those of other
drugs that are genotoxic, such as specific classes of an-
tibiotics and anticancer agents.
Technical variation within a study should be minimized.
Sample collection and storage should be standardized.
Studies in which samples cannot be frozen within a day ofcollection should consider a preservation method, although
even preserved samples should be frozen at −80 °C for
long-term storage [76, 77]. If possible, samples should be
processed together using the same reagents. If this is not
possible because of the size of the study, samples should be
randomized to minimize the confounding of technical and
biological variables [91]. The use of standard processing
pipelines, like those described by the Earth Microbiome
Project [104, 105], may facilitate data aggregation for
meta-analyses. Participation in standardization efforts,
such as the Microbiome Quality Control Project
(http://www.mbqc.org/) and the Unified Microbiome
Initiative [106], can help to identify sources of lab-to-
lab variation.
Conclusions
Microbiome research is rapidly advancing, although sev-
eral challenges that have been tackled in other fields, in-
cluding epidemiology, ecology, and human genetic studies
(in particular, genome-wide association studies), need to
be addressed fully. First, technical variation still makes it
difficult to compare claimed effect sizes, or claimed asso-
ciations of particular taxa with particular phenotypes.
Standardized methods, including bioinformatics protocols,
will help immensely here. This is particularly an issue for
translational studies between humans and animal models,
because it can be difficult to determine whether differ-
ences in microbial communities or host responses to these
changes are due to differences in the host physiology or
variation in the variable of interest. However, the potential
payoff for translation of microbiome results from high-
throughput animal models, such as flies or zebrafish, to
humans, is enormous.
In this review, we have focused mainly on 16S rRNA
amplicon analysis and shotgun metagenomic studies be-
cause these are most prevalent in the literature at
present. However, microbiome studies are continuing to
expand, such that a single study can include multi-omics
techniques such as metatranscriptomics, metaproteomics,
and metabolomics. Before we embark too far on the ex-
ploration of multiomics datasets, methods standardization
across multiple platforms will be necessary to facilitate ro-
bust biological conclusions, despite the considerable cost
of such standardization efforts.
Overall, the field is converging on many conclusions
about what does and does not matter in the microbiome:
improved standards and methodologies will greatly accel-
erate our ability to integrate and trust new discoveries.
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